Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/6155
Title: Helicobacter pylori seropositivity in fibromyalgia syndrome [Article]
Authors: Akkaya, Nuray
Akkaya, S.
Polat, Y.
Turk, M.
Turk, T.
Turhal, E.
Sahin, F.
Keywords: Fibromyalgia syndrome
Helicobacter pylori extragastric manifestations
Helicobacter pylori infection
immunoglobulin A antibody
immunoglobulin G antibody
adult
article
controlled study
disease association
disease severity
enzyme linked immunosorbent assay
female
fibromyalgia
Helicobacter infection
Helicobacter pylori
human
major clinical study
priority journal
questionnaire
Adult
Case-Control Studies
Enzyme-Linked Immunosorbent Assay
Female
Fibromyalgia
Helicobacter Infections
Humans
Immunoglobulin A
Immunoglobulin G
Inflammation
Middle Aged
Questionnaires
Seroepidemiologic Studies
Syndrome
Abstract: Although there are some studies suggesting relation between different types of infection and fibromyalgia syndrome (FM), there is presently no proof that FM is caused by an infection. Helicobacter pylori (HP) infection may cause extragastric manifestations. Inflammation is an important mediator of increased sympathetic nervous system activity and may lead to pain in fibromyalgia patients. In this study, we aimed to investigate the HP seropositivity in fibromyalgia patients compared with controls for possible role of HP infection in FM. Sixty-seven patients with fibromyalgia were evaluated. Two of them were excluded from the study because of high level of acute phase reactants. Sixty-five female patients with fibromyalgia and 41 randomly selected age-matched female healthy controls were enrolled to study. Serum HP IgA and IgG antibodies were measured by enzyme-linked immunosorbent assay technique. Fibromyalgia Impact Questionnaire was assessed in patients and controls. Seropositivity of HP IgG antibody in the fibromyalgia patients was significantly higher than in the control group. No statistically significant differences were found regarding the clinical features between fibromyalgia patients with HP IgG antibody and patients without IgG antibody. Our study suggests that former HP infection may have a role in the etiopathogenesis of fibromyalgia syndrome or may act as a triggering factor. However, high seroprevalence of HP in general population and prevalent asymptomatic infection make it difficult to interpret these results for the definite role of HP in FM. Highlighting the pathophysiologic mechanisms of FM will result in more effective treatment regimens. © Clinical Rheumatology 2010.
URI: https://hdl.handle.net/11499/6155
https://doi.org/10.1007/s10067-010-1618-9
ISSN: 0770-3198
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

12
checked on Dec 14, 2024

WEB OF SCIENCETM
Citations

15
checked on Dec 19, 2024

Page view(s)

52
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.